Extrachromosomal DNA in the cancerous transformation of Barrett’s oesophagus
University of California San Diego · University of Cambridge · +15 more institutions
Abstract
. At present, it is unclear whether ecDNA is a later manifestation of genomic instability, or whether it can be an early event in the transition from dysplasia to cancer. Here, to better understand the development of ecDNA, we analysed whole-genome sequencing (WGS) data from patients with oesophageal adenocarcinoma (EAC) or Barrett's oesophagus. These data included 206 biopsies in Barrett's oesophagus surveillance and EAC cohorts from Cambridge University. We also analysed WGS and histology data from biopsies that were collected across multiple regions at 2 time points from 80 patients in a case-control study at the Fred Hutchinson Cancer Center. In the Cambridge cohorts, the frequency of ecDNA increased…
Citation impact
- FWCI
- 43.93
- Percentile
- 100%
- References
- 68
Authors
20Topics & keywords
- Medicine
- Dysplasia
- Cancer
- Stage (stratigraphy)
- Internal medicine
- Biopsy
- Oncology
- Gastroenterology
- Good health and well-being
Funding
- CPCancer Prevention and Research Institute of TexasAward: RR210034
- CRCancer Research UKAwards: 100012, CGCATF-2021/100012, CGCATF-2021/100023, C98/A24032, CGCATF-2021/100025
- NINational Institute for Health and Care ResearchAward: CA015704
- MOMinistry of Food and Drug SafetyAward: 21153MFDS607
- MOMinistry of Science and ICT, South KoreaAwards: 2019R1A5A2027340, NRF-2019R1A5A2027340
- AGArctic Goose Joint Venture
- NINational Institutes of HealthAwards: P30 CA023100, CA015704, U24CA264379, CA034196, R21 NS114873, R01 CA237208, P30 CA015704, R01ES032547-01, R01ES030993, R01GM114362, R33 CA236681, CA023100, P30 CA034196, R21 CA256575
- UOUniversity of California, San Diego
- SUStand Up To CancerAward: SU2C-AACR-DT25-17
- MRMedical Research CouncilAwards: MR/W014122/1, C98/A24032
- NCNational Cancer InstituteAwards: P30 CA015704, CA91955, UG1CA242596, OT2CA278635, R01 CA237208, CA023100, CA015704, OT2CA278649, OT2CA278688, R01GM114362, R01ES030993, U24CA264379, HHSN261201200031I, CA034196, R01ES030993-01A1, P30 CA034196, P30 CA023100, R33 CA236681
- NINational Institute of Neurological Disorders and StrokeAwards: R21 NS114873, 100016